| Literature DB >> 33004082 |
Bokun Kim1,2, Minjae Ku3, Tanaka Kiyoji4, Tomonori Isobe1, Takeji Sakae1, Sechang Oh5.
Abstract
BACKGROUND: Maintaining a good level of physical fitness from engaging in regular exercise is important for the treatment and prevention of metabolic syndrome (MetS). However, which components constitutive of physical fitness confer the greatest influence remains controversial. This retrospective cross-sectional study aimed to investigate the association between MetS and physical fitness components including cardiorespiratory fitness, muscle strength, flexibility, and agility and to identify which physical fitness components have the largest influence on MetS.Entities:
Keywords: Cardiorespiratory fitness; Metabolic syndrome; Physical fitness
Mesh:
Year: 2020 PMID: 33004082 PMCID: PMC7528584 DOI: 10.1186/s40101-020-00241-x
Source DB: PubMed Journal: J Physiol Anthropol ISSN: 1880-6791 Impact factor: 2.867
Fig. 1Flow diagram of study participants’ enrollment and classification
Anthropometric and body composition characteristics and trends among three groups
| Non-MetS group (A) | Pre-MetS group (B) | MetS group (C) | Post hoc | SSb | ||
|---|---|---|---|---|---|---|
| ( | ( | ( | ||||
| Age, year | 50.5 ± 9.7 (47.9, 53.1) | 49.4 ± 9.6 (46.8, 51.9) | 49.7 ± 7.9 (47.6, 52.8) | NS | − 0.65 | = 0.51 |
| Height, cm | 169.1 ± 5.5 (167.6, 170.6) | 172.2 ± 6.5 (170.4, 173.9) | 172.8 ± 5.4 (171.3, 174.2) | A < B, C | 3.56 | < 0.01 |
| Weight, kg | 73.8 ± 10.4 (71.0, 76.6) | 86.2 ± 13.9 (82.5, 89.8) | 86.8 ± 9.7 (84.3, 89.4) | A < B, C | 5.86 | < 0.01 |
| BMI, kg/m2 | 25.8 ± 3.3 (24.9, 26.7) | 28.9 ± 3.5 (28.0, 29.9) | 29.1 ± 3.2 (28.3, 30.0) | A < B, C | 4.99 | < 0.01 |
| WLM, kg | 59.6 ± 8.1 (57.4, 61.8) | 63.8 ± 7.2 (61.9, 65.7) | 63.9 ± 7.6 (61.9, 65.9) | A < B, C | 3.01 | < 0.01 |
| WFM, kg | 19.1 ± 5.3 (17.6, 20.5) | 22.6 ± 5.6 (21.1, 24.1) | 22.3 ± 5.3 (20.9, 23.8) | A < B, C | 3.20 | < 0.01 |
| %WFM | 23.7 ± 4.1 (22.6, 24.8) | 25.6 ± 4.0 (24.5, 26.7) | 25.3 ± 3.7 (24.3, 26.3) | A < B | 2.09 | < 0.05 |
| TLM, kg | 29.1 ± 3.9 (28.0, 30.1) | 31.8 ± 3.9 (30.7, 32.8) | 32.1 ± 4.0 (31.0, 33.2) | A < B, C | 3.93 | < 0.01 |
| TFM, kg | 9.9 ± 3.1 (9.0, 10.7) | 12.1 ± 3.9 (11.1, 13.1) | 12.2 ± 3.3 (11.3, 13.1) | A < B, C | 3.65 | < 0.01 |
| %TFM | 24.8 ± 4.8 (23.5, 26.1) | 26.9 ± 5.5 (25.5, 28.4) | 27.0 ± 4.7 (25.8, 28.3) | NS | 2.33 | < 0.05 |
| ALM, kg | 6.0 ± 1.9 (5.5, 6.5) | 6.9 ± 1.1 (6.6, 7.1) | 6.3 ± 1.6 (5.9, 6.8) | A < B | 1.23 | = 0.22 |
| AFM, kg | 1.9 ± 0.7 (1.7, 2.1) | 2.5 ± 0.7 (2.3, 2.6) | 2.2 ± 0.7 (2.0, 2.4) | A < B | 2.05 | < 0.05 |
| %AFM | 24.0 ± 4.9 (22.7, 25.4) | 25.8 ± 4.8 (24.5, 27.0) | 25.2 ± 4.0 (24.1, 26.3) | NS | 1.34 | = 0.18 |
| LLM, kg | 17.9 ± 5.3 (16.5, 19.3) | 20.4 ± 3.1 (19.5, 21.2) | 18.5 ± 4.6 (17.3, 19.8) | A < B | 0.98 | = 0.35 |
| LFM, kg | 5.3 ± 2.0 (4.8, 5.9) | 6.7 ± 1.8 (6.3, 7.2) | 5.8 ± 2.1 (5.3, 6.4) | A < B, B > C | 1.39 | = 0.17 |
| %LFM | 22.6 ± 4.5 (21.4, 23.8) | 24.3 ± 4.1 (23.2, 25.3) | 23.2 ± 4.0 (22.1, 24.3) | NS | 0.78 | = 0.43 |
NOTES: Values are means±SD
95% CI 95% confidence interval, NS not significant, non-MetS non-metabolic syndrome, pre-MetS pre-metabolic syndrome, MetS metabolic syndrome, SS standardized statistic, BMI body mass index, WLM whole body lean mass, WFM whole body fat mass, %WFM percentage of whole body fat mass, TLM trunk lean mass, TFM trunk fat mass, %Trunk mass percentage of trunk fat mass, ALM arm lean mass, AFM arm fat mass, %AFM percentage of arm fat mass, LLM leg lean mass, LFM leg fat mass, %Leg fat mass percentage of leg fat mass
bJonckheere-Terpstra test was used to assess the trend among three groups
Characteristics of components of metabolic syndrome and trends among three groups
| Non-MetS (A) | Pre-MetS (B) | MetS (C) | Post hoc | SSb | ||
|---|---|---|---|---|---|---|
| ( | ( | ( | ||||
| Abdominal obesity | ||||||
| WC, cm | 93.0 ± 8.4 (90.7,95.3) | 101.1 ± 8.9 (98.8,103.5) | 101.5 ± 7.0 (99.7,103.4) | A < B, C | 5.04 | < 0.01 |
| %Abdominal obesity | 80.0 | 100.0 | 100.0 | |||
| Dyslipidemia | ||||||
| TG, mg·dL-1 | 90.8 ± 38.7 (80.4,101.3) | 137.5 ± 96.9 (111.7,163.2) | 247.5 ± 166.6 (202.9,292.1) | A, B < C | 8.17 | < 0.01 |
| HDLC, mg·dL-1 | 56.3 ± 9.2 (53.8,58.8) | 48.8 ± 10.9 (45.9,51.8) | 47.3 ± 10.7 (44.5,50.2) | A > B, C | -4.44 | < 0.01 |
| %Dyslipidemia | 1.8 | 31.6 | 85.7 | |||
| Hypertension | ||||||
| SBP, mmHg | 116.8 ± 9.2 (114.3,119.3) | 127.0 ± 13.6 (123.4,130.6) | 135.6 ± 12.1 (132.4,138.9) | A < B < C | 7.34 | < 0.01 |
| DBP, mmHg | 77.1 ± 6.9 (75.2,78.9) | 86.6 ± 9.2 (84.1,89.0) | 93.5 ± 8.3 (91.2,95.6) | A < B < C | 8.68 | < 0.01 |
| %Hypertension | 9.1 | 63.2 | 98.2 | |||
| Hyperglycemia | ||||||
| FPG, mg/dL | 90.7 ± 6.7 (88.9,92.5) | 94.5 ± 9.0 (92.1,96.9) | 114.1 ± 37.5 (104.1,124.2) | A, B < C | 6.13 | < 0.01 |
| %Hyperglycemia | 0.0 | 3.5 | 42.6 | |||
NOTES: Values are means±SD
95% CI 95% confidence interval, non-MetS non-metabolic syndrome, pre-MetS pre-metabolic syndrome, MetS metabolic syndrome, SS standardized statistic, WC waist circumstance, %Abdominal obesity percentage of abdominal obesity, TG triglycerides, HDLC high-density lipoprotein cholesterol, %Hypertension percentage of hypertension, FPG fasting plasma glucose, %Hyperglycemia percentage of hyperglycemia
bJonckheere-Terpstra test was used to assess the trend among three groups
Characteristics of components of physical fitness and trends among three groups
| Non-MetS (A) | Pre-MetS (B) | MetS (C) | Post hoc | SSb | ||
|---|---|---|---|---|---|---|
| ( | ( | ( | ||||
| VO2AnT (ml·kg·min-1) | 19.12 ± 4.16 (17.99, 20.24) | 16.51 ± 3.27 (15.64, 17.38) | 16.54 ± 5.01 (15.20, 17.88) | A > B, C | − 3.68 | < 0.01 |
| VO2max (ml·kg·min-1) | 33.70 ± 5.49 (32.22, 35.19) | 30.51 ± 5.02 (29.18, 31.84) | 29.60 ± 5.33 (28.17, 31.03) | A > B, C | − 3.78 | < 0.01 |
| Right hand grip strength (kg) | 43.43 ± 7.15 (41.49, 45.36) | 44.12 ± 8.09 (41.98, 46.27) | 43.96 ± 5.58 (42.47, 45.45) | NS | 0.45 | = 0.66 |
| Left hand grip strength (kg) | 41.76 ± 6.63 (39.96, 43.55) | 43.83 ± 7.66 (41.80, 45.86) | 41.43 ± 6.22 (39.76, 43.09) | NS | 0.09 | = 0.93 |
| Stepping side-to-side (n/20 s) | 41.04 ± 7.92 (38.90, 43.18) | 38.41 ± 5.82 (36.79, 39.88) | 38.43 ± 5.92 (36.84, 40.01) | NS | − 1.64 | = 0.10 |
| Trunk flexion (cm) | 0.21 ± 9.76 (-2.43, 2.85) | -3.09 ± 9.58 (-5.63, -0.54) | − 2.76 ± 9.39 (− 5.27, − 0.24) | NS | − 1.55 | = 0.12 |
| Trunk extension (cm) | 40.49 ± 9.45 (37.94, 43.04) | 38.56 ± 8.47 (36.32, 40.81) | 41.77 ± 8.83 (39.40, 44.13) | NS | 0.61 | = 0.54 |
| Vertical jump (cm) | 42.80 ± 7.91 (40.66, 44.94) | 41.95 ± 6.95 (40.10, 43.79) | 42.73 ± 8.12 (40.56, 44.91) | NS | − 0.13 | = 0.89 |
| Single-leg balance with eyes closed (s) | 19.13 ± 19.30 (13.91, 24.34) | 12.24 ± 12.86 (8.83, 15.65) | 12.96 ± 13.87 (9.25, 16.68) | NS | − 1.75 | = 0.08 |
NOTES: Values are means±SD
95% CI 95% confidence interval, NS not significant, non-MetS non-metabolic syndrome, pre-MetS pre-metabolic syndrome, MetS metabolic syndrome, SS standardized statistic
bJonckheere-Terpstra test was used to assess the trend among three groups
Fig. 2Association between cardiorespiratory fitness and pre-MetS and MetS. a Association between VO2peak and pre-MetS and MetS. b Association between VO2AnT and pre-MetS and MetS. pre-MetS pre-metabolic syndrome, MetS metabolic syndrome, VO2peak peak oxygen consumption, VO2AnT oxygen uptake at anaerobic threshold, Q I quartile I, Q II quartile II, Q III quartile III